Objectives-The purpose of this study was to consecutively capture and quantify nitric oxide (NO) and cGMP, the second messenger of NO, over the skin surface of acupuncture points (acupoints), meridian line without acupoint, and non-meridian control regions of the Pericardium meridian (PC) in humans, and investigate their response to transcutaneous electrical nerve stimulation (TENS).
Introduction
Transcutaneous electrical nerve stimulation (TENS) and transcutaneous electrical stimulation of acupuncture points (acupoints, TESA) provide a safe, standardized technique without invasive acupuncture needle insertion and is widely accepted as an alternative therapy for pain relief in the community [1, 2] . Several studies have demonstrated that TENS and TESA produce analgesic effects, reduce the need for pain medication, and increase physical functionality [2] [3] [4] . A number of studies have demonstrated that localized TENS augments microcirculation and angiogenesis, thus having wound-healing applications in animal and human subjects [2, [6] [7] [8] . TENS, acupuncture, and acupuncture-like stimulation affects regional blood flow in skin, and produces changes in arterial blood pressure and blood nitric oxide (NO) level [9] [10] [11] . Thus, it is suggested that TENS potentially can improve symptoms caused by peripheral vascular diseases [7, 8, 12] . However, the effects, biochemical changes, and mechanism responsible for the beneficial effects induced by TENS/TESA are not well known.
The Meridian System (Jingluo) described in Traditional Chinese Medicine is an essential pathway system and the core theory of acupuncture, related to TENS and TESA [13] [14] [15] . International studies in both humans and animals have shown that acupoints possess characteristics of low electrical resistance (LER) and high electric conductance [14] [15] [16] [17] [18] [19] [20] . Several reports have demonstrated that LER is present not only over the skin surface of acupoints, but also over entire meridian lines (about 1.0 mm in width) as described in traditional charts [14, 15, 20] . Morphological studies have identified that most acupoints are located intimately at the distribution of nerve trunks, blood vessels, sweat glands, and hair follicles [19] [20] [21] .
It is well-documented that NO is one of the most important messenger molecules, and NO synthase (NOS) expression is exhibited in the skin tissue [22] [23] [24] . Figure 1 shows that NO can be produced enzymatically by NOS or non-enzymatically through the nitrate-nitrite-NO pathway, and NO stimulates guanylyl cyclase to generate cyclic guanosine monophosphate (cGMP), a second messenger directing vasodilatation and various biological functions [25, 26] . NO has a half-life of a few seconds due to rapid oxidation to both nitrite and nitrate [27, 28] , and measurements of total nitrite and nitrate (NO x -), stable end products of NO metabolism, are very adequate indicators of the changes in NO activity and its production in the tissue [27] [28] [29] , as shown in figure 1 . Investigators have developed an NO-scavenging compound, 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO), which has been used to convert NO into stable measurable nitrite in biological systems [30, 31] . Previous studies described a connection between neurotransmitters and organs corresponding to acupuncture points by using an indirect measurement, but requires validation [32] . Our recent studies have developed a painless, non-invasive device to capture and directly quantify NO metabolites using PTIO solution incubated over skin surfaces of acupoints/ meridians [33, 34] . We have demonstrated, using this biocapture device, that NO levels are increased over acupoints compared to meridian lines without acupoint (MWOP) and nonmeridian control regions (NMCR) in humans [23] .
The purpose of this study is to quantify the changes in concentrations of NO x -along the skin surface of the acupoints of the Pericardium meridian (PC) compared to their corresponding MWOP and NMCR during consecutive biocaptures in humans. Whether NO-cGMP releases are modified by TENS and whether the effects of TENS-induced NO-cGMP releases are specific to acupoints and/or meridians, are determined by quantification of the molecules along the PC region following the treatments.
Materials and Methods

Human Subjects
Twenty six men and women (18-to 55-years-old), recruited at Harbor-UCLA Medical Center, volunteered for the following studies. All participants were healthy subjects who did not have major surgery in the past 12 months nor history of cardiovascular disease. Subjects with dermatological problems, allergic diseases, vascular disorders, infectious diseases, and prescribed medication were excluded from the study. The protocol was approved by the John F. Wolf, MD Human Subjects Committee of the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. Subjects were given a detailed oral instruction of the study, and their informed consent was obtained. Female participants were not on their menstrual period on the day of study. Experiments were performed in a quiet, airconditioned room with the temperature maintained at 25-27 °C. Researchers operating the chemiluminescence Nitrogen Oxide Analyzer and analyzing the data were blinded to treatments of the subjects.
Identification of Acupoints and Transcutaneous Electrical Nerve Stimulation (TENS)
The region of acupoints, MWOP, and NMCR over the PC meridian of the ventral forearm were studied in each subject as described in Figure 2 . Locations were identified by an acupoint/meridian map of the human body [13, 15] . These regions were chosen in the experiments for the following reasons: 1) Acupoints/meridians in these regions can be easily and consistently identified on the body surface; and 2) There is enough space to place NO biocapture tubes without touching other meridians [33, 34] . TENS was performed using a battery powered acupuncture stimulator to generate a current of 1.0 mA at 6 Hz for a duration of 1.0 msec [35] . The stimulation was applied to the skin surface of PC 8 (cathode) on the hand and PC 3 (anode) on the upper forearm as a pair through a stimulation electrode for 20 min.
Instrumentation and NO Biocapture
Acupoints, MWOP, and NMCR were defined as described above, and the biocapture method was described previously in humans [33, 34] . A biocapture device, developed by this lab, consists of a molded semi-circular silicone-plastic tube (0.5 × 5 cm), which is adhered to the ventral forearm skin using a custom double-sided adhesive, as shown in Figure 2 [34] . PTIO solution (100 μM) was injected inside the sterilized tube and in direct contact with the surface of the skin for 20 min to absorb NO. After the 20 min incubation, the liquid was collected from the tubes adhered over acupoints, MWOP, and NMCR. Following the first biocapture, the PTIO solution was then replaced and collected at 20 min each for the 2 nd , 3 rd and 4 th biocaptures. The liquid was transferred to a plastic vial and stored in -80 °C. The concentrations of total nitrite plus nitrate (NO x -) and cGMP in the samples were quantified using chemiluminescence and ELISA in a blinded fashion, respectively [33] [34] [35] .
Quantification of NO Metabolites and cyclic GMP
The total NO x -concentration (NO 2 -and NO 3 -) was measured in the biocapture solution using an ozone phase chemiluminescence method (Sievers NOA280i, GE Analytical Instruments, Boulder, CO) as described previously [33] [34] [35] . Briefly, 5 μl samples were reduced using a Vanadium (III)/HCl solution. The nitrate calibration curve was established using known concentrations of NaNO 3 dissolved in the sterile nitrogen-free water. The total amount of NO 3 -in each collecting sample was calculated by integration of the signal peaks using the nitrate calibration curve. All samples were measured in duplicate. The presence of (NO 2 -) in our collecting samples was close to the water basal level. The minimum sensitivity level of NO amount is 1.0 picomole.
The concentration of cGMP in the biocapture samples was assayed using a competitive Enzyme-Linked Immunosorbent Assay (Parameter™ Cyclic GMP Assay, R&D Systems, Minneapolis, MN) following manufacturer's protocol [34, 35] . For the sample preparation, 40 μl biocapture sample was diluted in 60 μl Calibrator Diluent RD5-5. The optical density of yellow color development in the wells was read using a microplate reader set to 450 nm with a wavelength correction to 570 nm (Molecular Devices Emax, Sunnyvale, CA). The minimal detection level of cGMP is 1.14 pmol/ml.
Research Protocols
Volunteers were randomly asked to participate in consecutive biocaptures over PC meridian region either with or without TENS. The NO capturing tubes were taped to the left and right ventral forearm along PC acupoints, MWOP and NMCR, and filled with PTIO solution. In order to measure baseline changes in NO x -concentrations and assess the influence of cumulative NO on the skin surface, four consecutive biocaptures were performed for a period of 80 min over 20 min interval each, respectively.
In the TENS study, the biocapture devices were taped to the skin surface of the PC meridian region on both the left and right forearms, and the 1 st biocapture was conducted as described above. TENS was performed over PC 8-PC 3 as a pair on one side of the arm on the skin surface for 20 min; the left or right arm was randomly treated, while the other arm served as self controls in a randomized fashion. Following the 1 st biocapture, the PTIO solution was replaced and collected at 20 min during TENS. The liquid was drained from the tubing, and concentrations of NO x -and cGMP were quantified at 20 min each during the stimulation at the stimulated side compared to the control side without the treatment [35] .
Statistical Analysis
Results were expressed as mean ± standard error of the mean (SEM) of NO x -and cGMP concentrations over the skin surface, measured in the biocapture solution as concentration (μM and nM) and as efflux rate calculated over the surface area (length times width, nmol or pmol/cm 2 ) for 20 min along the skin surface that was in direct contact with the solution, respectively. The significance of differences were determined by three factor-repeated Analysis of Variance (ANOVA), where the three factors are (1) 
Results
Baseline NO metabolites over the PC meridian regions during 4 consecutive biocaptures
The baseline NO x -concentrations on the skin surface of PC meridian regions were examined in 13 healthy volunteers. Figure 2 is a representative example of the location of acupoints, MWOP, and non-meridian control along the PC on the forearm. As shown in figure 2 (right panel), a semi-circular plastic tube was taped to the skin surface over acupoints PC 4-6, between PC 3 to 4 defined as MWOP, and adjacent to the defined PC acupoints as NMCR. between consecutive biocaptures in different time periods in the 8 subjects over PC acupoints, MWOP, and NMCR (F = 23.9, P < 0.001). NO x -concentrations biocaptured during the 1 st interval over PC acupoints, MWOP, and NMCR were markedly and consistently higher than those during the 2 nd , 3 rd , and 4 th subsequent biocaptures (P < 0.05). There were no detectable differences among the 2 nd , 3 rd , and 4 th subsequent biocaptures, as shown in figure 3 . The baseline NO x -concentrations during the 2 nd biocapture over PC acupoints, MWOP, and NMCR were 45.0 ± 5.4 %, 44.7 ± 8.2 %, and 33.7 ± 5.74 % (mean ± SE) less than the 1 st biocapture. In the 1 st biocapture, baseline NO x -concentration (μM) over PC acupoints was significantly elevated compared to the NMCR (P < 0.05). However, no significant differences were found among NO x -concentrations among the sites of acupoints, MWOP, and NMCR in the subsequent biocaptures, as shown in figure 3 . Figure 4 shows NO x -concentration measured in the biocapture solution (μM) and efflux rate calculated over the surface area (nmol/cm 2 ) of PC acupoints, MWOP, and NMCR on one side compared to the opposing side (self-control) without treatment. NO x -concentration was significantly increased over PC acupoints and NMCR following TENS compared to the non-stimulation side (P < 0.05), as shown in figure  4 .
Effects of TENS on cGMP Releases over PC Acupoints/Meridians
cGMP releases over the PC meridian regions in response to TENS of PC 8-PC 3 pair were examined in 13 healthy volunteers during the same period of the TENS-induced NO biocapture, which was during the 2 nd biocapture after conducting the 1 st biocapture. cGMP release over a 20 min interval on skin regions along the PC acupoint and NMCR was measured on one side compared to the opposing side (self-control) without treatment during the stimulation period. Figure 5 shows the cGMP concentrations measured in the biocapture solution (nM) and efflux rate calculated over the surface area that is in contact with the biocapture solution over a 20 min duration (pmol/cm 2 ). cGMP concentrations were significantly increased by TENS over PC acupoints (P < 0.05) but not on NMCR. At the self-control side during the 2 nd biocapture, cGMP concentrations at the acupoint are significantly lower compared to those of the NMCR (P < 0.05).
Discussion
The purpose of this study was to consecutively biocapture NO over the skin surface of acupoints, MWOP, and NMCR along the PC meridians using a biocapture method in humans. The influences of TENS on NO-cGMP releases were examined by chemical analysis of the samples biocaptured over PC acupoints compared to MWOP and NMCR following the treatments. The major new findings of these studies are that: 1) Baseline NO content was higher over PC acupoints than NMCR during the 1 st biocapture, while there were no detectable differences among the 2 nd , 3 rd , and 4 th consecutive biocaptures; 2) NO contents over PC acupoints, MWOP, and NMCR were markedly and consistently reduced during the subsequent consecutive biocaptures compared to the 1 st biocapture; 3) TENS produced an increase in NO x -level over PC acupoints and NMCR; and 4) cGMP release was increased over PC acupoints but not on NMCR following TENS. This is the first evidence showing that TENS induces both NO and cGMP releases over PC acupoints. NO releases over the skin surface of the PC meridian region can be consecutively biocaptured and quantified on skin acupoints/meridians. NO contents biocaptured during the 1 st interval over PC acupoints and NMCR are almost two fold higher compared to subsequent biocaptures. Baseline NO level is higher at acupoints compared to the NMCR. These findings suggest that both cumulative NO and newly generated NO exist on the skin surface with higher level of cumulative NO over PC acupoints at the physiological level. Newly generated NO-cGMP molecules over acupoints were elevated by TENS, which improve local circulation and/or produce somatosensory signal transduction processes, and contribute to its therapeutic effects.
Our previous studies have demonstrated that NO metabolites are successfully biocaptured over the skin surface in humans using a painless and non-invasive biocapture device, and that concentrations of total nitrite and nitrate (NO x -) are higher over acupoints compared to NMCR in humans [33, 34] . The present study shows that the baseline NO level over PC acupoints is only higher than the NMCR during the 1 st biocapture but not during the 2 nd , 3 rd , and 4 th consecutive biocaptures. These results are consistent with our previous study reporting that both L-arginine-derived NO synthesis and non-enzymatic reduction of nitrate by bacteria are involved in NO generation on the skin [33] . The present results suggest that cumulative NO mainly contributes to higher levels of NO signal molecules over PC acupoints at the physiological level. This innovative biocapture method is applicable to systematic investigations of both cumulative NO and newly generated NO, and of differences in distribution of NO concentrations over various acupoints and meridian lines during physiological and pathological changes as well as following therapeutic treatments.
The sources and mechanisms of TENS-induced NO-cGMP molecules are not clear. Anatomical studies have identified that the number of nerve fibers/trunks, blood vessels, hair follicles, and sweat glands are enhanced over acupoints compared to their adjacent control areas [19] [20] [21] . Our previous studies have demonstrated that NOS protein levels and NO contents are consistently higher in skin regions containing acupoints/meridian lines compared to control tissues in rats [29, 36] . EA stimulation induces a significant release of NO following dermal microdialysis in the acupoint but not in the NMCR in humans [35] . Larginine-derived NO synthesis increases low resistance characteristics of acupoints [37] , and norepinephrine turnover rate in acupoints/meridians is facilitated by presence of NO [38] . Consistently, cutaneous vasodilation induced by acupuncture stimulation in the forearms of humans is attenuated by application of NO synthesis inhibitor, which suggest that Larginine-derived NO synthesis contributes to cutaneous vasodilation induced by acupuncture stimulation [39] . The present results support the possibility that TENS-induced NO generation/release is through L-arginine-derived NO synthesis, since the cumulative NO that mainly comes from non-enzymatic NO generation was already removed by the 1 st biocapture. TENS-induced NO-cGMP generation/release predominantly over acupoints agree with previous studies reporting that tissue NO level is high in acupoints, and further suggests that TENS-induced NO-cGMP are mainly from newly-generated molecules. Elevation of NO-cGMP in the acupoint could be achieved through the activation of endothelial and/or neuronal NO synthesis/release system.
TENS stimulation of acupoints and/or painful areas provide a safe, standardized technique and is widely accepted as an alternative therapy for benefiting pain and local circulation in the community [2] [3] [4] . Several reports have demonstrated that electrical stimulation causes multiple biological responses in both animals and humans [2, [6] [7] [8] . These responses can occur locally at or close to the site of the stimulation, or at a distance that is mediated mainly by the neuroendocrine system, and can affect various physiological functions [3] [4] [5] [6] . Acupuncture essentially improves local circulation and allows for a flush of analgesic or sensitizing substances, leading to pain relief [40] [41] [42] [43] . Previous studies showed that TENS, acupuncture, and acupuncture-like stimulation modifies regional blood flow in skin and changes arterial blood pressure and blood NO level [9] [10] [11] . Our results from TENS studies consistently suggest that newly generated NO-cGMP at acupoints is induced by electrical stimulation. Enhanced NO stimulates guanylyl cyclase to generate cGMP, and cGMP induces vasodilatation, which improves local microcirculation and removes pathological sensitizing substances. NO-cGMP may also produce analgesic action, and inhibits releases of inflammatory agents. All of these contribute to biochemical/physiological improvement and beneficial effects of the therapies.
Conclusion
In summary, the results show that baseline NO levels biocaptured during the 1 st interval over all PC regions are almost two fold higher compared to the subsequent biocaptures. PC acupoints exude a higher cumulative NO level compared to the NMCR during the 1 st biocapture. Newly generated NO release during the 2 nd biocapture over PC acupoints and NMCR is induced by TENS. Following TENS, cGMP is predominantly released/generated from the skin surface of PC acupoints. The results suggest that NO-cGMP signal molecules are elevated by TENS with a higher level specifically at acupoints. Improvement of local circulation by enhanced NO-cGMP releases contribute to the beneficial effects of the therapies, and this study demonstrates an innovative biocapture method applicable for monitoring therapeutic treatments. Nitric oxide (NO) in the skin tissue is produced enzymatically from L-arginine by nitric oxide synthase and non-enzymatically from bacterial reduction of nitrate through the nitratenitrite-NO pathway present in sweat and epidermis. NO stimulates soluble guanylyl cyclase to generate cGMP, which causes vasodilatation and other biological functions. NO rapidly oxidizes into nitrite (NO 2 -) and nitrate (NO 3 -), and measurements of these stable metabolites (NO x -, total nitrite plus nitrate) adequately indicate changes in NO activity and production in tissues.
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Fig. 2. Representation of a Biocapture Device with a Semi-cylindrical Molded Tube Taped to the Skin Surface over Meridians
The pericardium meridian (PC or P, bottom left) lines and related acupuncture points are illustrated on the left panel. The region from PC 4 to 6 is defined as acupoint (PC-P, 3 acupoints), the distance between PC 3 to 4 is defined as meridian line without acupoint (PC-WO), and the non-meridian control region is adjacent to the PC meridian (PC-C). NO scavenging solution (100 μM PTIO) was injected into the tubing on the skin surface for 20 min in order to directly absorb NO. Concentrations of cGMP on acupoints and NMCR were measured along the PC meridian following electrical stimulation of PC 8-PC 3 pair on one arm selected at random, while the other arm served as its control. cGMP concentrations measured in the biocapture solution (nM, top) and efflux rate calculated over the surface area in contact with the biocapture solution over a 20 min duration (pmol/cm 2 , bottom) were significantly increased over PC acupoints and NMCR by TENS in the stimulated side compared to the side without stimulation. Each bar represents the mean values and vertical bars represent S.E.M. *: p<0.05, compared with non-meridian control; #: p<0.05, compared to untreated side.
